Search alternatives:
significantly affect » significantly affected (Expand Search), significant effect (Expand Search), significant effects (Expand Search)
significant causes » significant cause (Expand Search), significant causal (Expand Search), significant clusters (Expand Search)
causes increased » cases increased (Expand Search), use increased (Expand Search), values increased (Expand Search)
affect decrease » effects decreased (Expand Search), largest decrease (Expand Search)
significantly affect » significantly affected (Expand Search), significant effect (Expand Search), significant effects (Expand Search)
significant causes » significant cause (Expand Search), significant causal (Expand Search), significant clusters (Expand Search)
causes increased » cases increased (Expand Search), use increased (Expand Search), values increased (Expand Search)
affect decrease » effects decreased (Expand Search), largest decrease (Expand Search)
-
161
-
162
HR (95% CI) of all-cause mortality and cause specific mortality according to vitamin D status.
Published 2025Subjects: -
163
-
164
-
165
-
166
-
167
Table1_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx
Published 2024“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
-
168
Table2_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx
Published 2024“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
-
169
-
170
-
171
-
172
The table shows the significant and non-significant altered group with different parameters.
Published 2025Subjects: -
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180